Filter
1799
Filtered Results: 1799
Text search:
antigen
Featured
Recommendations
214
New Publications
411
Language
Document type
No document type
857
Guidelines
439
Studies & Reports
209
Manuals
99
Strategic & Response Plan
65
Fact sheets
64
Training Material
18
Situation Updates
18
Brochures
9
Infographics
9
Resource Platforms
5
Online Courses
4
Videos
3
Countries / Regions
India
84
Global
64
Germany
56
Brazil
54
Latin America and the Carribbean
40
Africa
35
Western and Central Europe
34
Nigeria
30
Kenya
30
South Africa
30
Congo, Democratic Republic of
27
Argentina
27
Uganda
24
Sierra Leone
22
Tanzania
22
Paraguay
22
Colombia
21
Nepal
20
Rwanda
20
East and Southern Africa
20
Philippines
19
Zambia
19
Ukraine
18
Liberia
17
Malawi
17
West and Central Africa
16
Senegal
15
Ethiopia
15
Ghana
15
Mozambique
15
Burkina Faso
14
Indonesia
13
Bangladesh
13
Russia
13
Cameroon
12
Zimbabwe
12
Bolivia
11
Chile
11
Middle East and North Africa
11
Namibia
10
Peru
10
Myanmar / Burma
10
El Salvador
9
South–East Asia Region
9
Venezuela
9
Ecuador
8
Syria
7
Madagascar
7
Eastern Europe and Central Asia
7
Guinea
6
Haiti
6
Benin
6
Angola
6
Lesotho
6
Eastern Europe
6
Pakistan
5
Asia
5
Mali
4
USA
4
Niger
4
Somalia
4
Cambodia
4
Central African Republic
4
Botswana
4
Spain
4
Côte d’Ivoire / Ivory Coast
3
Saudi Arabia
3
South Sudan
3
Afghanistan
3
Papua New Guinea
3
Sudan
3
Honduras
3
Libya
3
Albania
3
Guinea-Bissau
2
Togo
2
Iraq
2
Jordan
2
Lebanon
2
Chad
2
Eswatini/ Swaziland
2
Guatemala
2
Western Pacific Region
2
Djibouti
2
Congo-Brazzaville
2
Iran
2
North America
2
France
2
Portugal
2
Morocco
1
Egypt
1
China
1
Dominican Republic
1
North Macedonia
1
Switzerland
1
Cuba
1
Burundi
1
Greece
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Yemen
1
Luxembourg
1
Palestine
1
Southern Africa
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Moldova
1
Kazakhstan
1
Georgia
1
Uruguay
1
Belgium
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
752
Clinical Guidelines
245
Pharmacy & Technologies
67
Public Health
66
Women & Child Health
40
Key Resources
28
Capacity Building
16
Toolboxes
COVID-19
359
HIV
155
TB
142
Rapid Response
124
NTDs
113
Ebola
61
Refugee
42
Pharmacy
29
Mental Health
28
Zika
25
Caregiver
23
Polio
18
Conflict
17
AMR
17
NCDs
14
Planetary Health
13
Cholera
10
Natural Hazards
9
Health Financing Toolbox
6
Specific Hazards
5
Global Health Education
5
Disability
1
Social Ethics
1
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
Taenia saginata is a zoonotic tapeworm that is of economic importance in countries where cattle are kept. The parasite is transmitted from human tapeworm carriers (taeniosis) to bovines (cysticercosis) by excretion of eggs or proglottids containing eggs into the environment via the stool. Bovines ca...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus...
Frequently Asked Questions on Visceral Leishmaniasis
Rabies is a disease of animals but too often the outcome is gauged in terms of human suffering and
death. Despite this, in areas of the world where rabies is endemic there is often a lack of communication between veterinary and medical professionals, to the extent that the disease continues to thri...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
BMJ Open 2021;11:e042279. doi:10.1136/bmjopen-2020-042279. Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnos...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
The longlist of knowledge gaps is based on existing research agendas published in 2015 or later and expert input from reviewers of the first draft of the longlist. It only includes knowledge gaps focussing on a better
understanding of the relationship between global environmental change and human h...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
The military offensive by the Russian Federation in Ukraine which began February 2022 has triggered one of the world’s fastest-growing displacement and humanitarian crisis, with geopolitical and economic ripples felt across the globe. The ongoing war has caused large-scale disruptions to the deliv...
Der Krieg der Russischen Föderation gegen die Ukraine hat Leid und Verwüstung in einem in der Europäischen Region der WHO seit Jahrzehnten nicht gekannten Ausmaß verursacht. In der Ukraine spielt sich eine sich rasch entwickelnde humanitäre und Flüchtlingskrise ab, deren geopolitische und wirt...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
